The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...

Onradivir significantly shortens recovery time in adults with uncomplicated influenza A. Read more. Learn more.

Abu Dhabi Public Health Centre (ADPHC) has vaccinated nearly 300,000 people across Abu Dhabi, Al Ain Region, and Al Dhafra with the seasonal flu vaccine as part of its 2024–2025 campaign, a 45 percent ...

RESVIA is now authorized for use in adults aged 18–59 years with an increased risk of respiratory syncytial virus-related ...

An 82-year-old on haemodialysis tests HIV-positive 7 months in, only for PCR to be negative, implicating flu shot antibody ...

Novavax's COVID-19-influenza vaccines show strong immune response in older adults, paving the way for regulatory approval.

The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety ...

South Africa will proceed with its long-awaited vaccination strategy against Highly Pathogenic Avian Influenza (HPAI), Deputy ...

In a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA (clesrovimab-cfor) , a ...

Explore why Novavax, Inc. faces profitability challenges despite a promising tech platform, with uncertain revenue streams.

The late biannual publication provides market assessments and updated forecasts for the production, trade, utilisation and ...

Infectious disease clinicians raised alarm that proposed cuts to Medicaid could affect ID-related services, not only among ...